Pure Global
NCT04949620

An Integrative Platform for Preventing Children's Emotional Disorders

REThinkWELL: An Evidence-based Integrative Platform for the Prevention of Emotional Disorders in Children
Babes-Bolyai University·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Emotional Problem
Drug/Device/Intervention
REThink therapeutic game
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Babes-Bolyai University
Location
Cluj-Napoca, Romania
Timeline & enrollment
Phase
N/A
Start date
May 03, 2021
End date
Sep 01, 2022
Enrollment
211 participants
Primary outcome

Children's emotional symptoms,Changes in children's emotional symptoms - immediately,Changes in children's emotional symptoms - post second stage,Changes in children's emotional symptoms - follow up,Changes in children's emotional symptoms - follow up one year

Summary

The general objective of the study is to test an online platform for the prevention of
 emotional disorders in children.

ICD-10 classifications
Childhood emotional disorder, unspecifiedSymptoms and signs involving emotional stateOther childhood emotional disordersOther symptoms and signs involving emotional stateState of emotional shock and stress, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04949620
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04949620 through Pure Global AI's free database. This phase not specified trial is sponsored by Babes-Bolyai University and is currently Recruiting. The study focuses on Emotional Problem. Target enrollment is 211 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.